Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
cancer
crispr
3
×
deals
editas medicine
life sciences
national
national blog main
national top stories
novartis
3
×
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
clinical trials
crispr therapeutics
detroit blog main
detroit top stories
europe blog main
fda
indiana blog main
indiana top stories
ipo
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
takeda pharmaceutical
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
What
bio
car
roundup
access
acquisitions
advanced
announced
bails
brand
bridgebio
capacity
capital
cell
ceo
collabs
consolidation
covid
crispr
daniel
deal
develop
drugs
emerges
falcon
firm
focus
gene
gilead
gilead’s
grab
headlines
help
ichnos
introduce
invest
ipo
life
medicines
milestones
millions
Language
unset
3
×
Current search:
crispr
×
unset
×
novartis
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More